Treatment of Neuronopathic Mucopolysaccharidoses with Blood-Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
Enzyme replacement therapy (ERT) has paved the way for treating the somatic symptoms of lysosomal storage diseases (LSDs), but the inability of intravenously administered enzymes to cross the blood-brain barrier (BBB) has left the central nervous system (CNS)-related symptoms of LSDs largely impervi...
Saved in:
Main Authors: | Hiroyuki Sonoda (Author), Kenichi Takahashi (Author), Kohtaro Minami (Author), Toru Hirato (Author), Tatsuyoshi Yamamoto (Author), Sairei So (Author), Kazunori Tanizawa (Author), Mathias Schmidt (Author), Yuji Sato (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
by: Rita Barone, et al.
Published: (2018) -
Neuronopathic Types of Mucopolysaccharidoses: Pathogenesis and Emerging Treatments
by: L. A. Osipova, et al.
Published: (2015) -
ENT and mucopolysaccharidoses
by: Pier Marco Bianchi, et al.
Published: (2018) -
Orthopaedic challenges for mucopolysaccharidoses
by: Andrea Borgo, et al.
Published: (2018) -
The new frame for Mucopolysaccharidoses
by: Rossella Parini, et al.
Published: (2018)